Bench to Cribside: The Path for Developing a Neuroprotectant

Translational Stroke Research

Volumn 4, Issue 2, 2013, Pages 258-277

  Ramanantsoa, Nelina ^a,b   Fleiss, Bobbi ^a,b,c   Bouslama, Myriam ^a,b   Matrot, Boris ^a,b   Schwendimann, Leslie ^a,b   Cohen Salmon, Charles ^a,b   Gressens, Pierre ^a,b,c   Gallego, Jorge ^a,b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Behavioral testing; Melatonin; Neuroprotectant; Preclinical

Indexed keywords

MELATONIN;

BRAIN INJURY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INCIDENCE; INDUCED HYPOTHERMIA; NEUROPHARMACOLOGY; NEUROPROTECTION; NONHUMAN; PERINATAL ASPHYXIA; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PREMATURITY; PRIORITY JOURNAL; REVIEW; THERAPY DELAY;

ANIMALS; BRAIN INJURIES; DRUG DESIGN; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT; INFANT, NEWBORN; NEUROPROTECTIVE AGENTS;

EID: 84875054654     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0233-2     Document Type: Review

References (168)

1. Thornton C, Rousset CI, Kichev A, Miyakuni Y, Vontell R, Baburamani AA, et al. Molecular mechanisms of neonatal brain injury. Neurol Res Int. 2012; 2012: 506320.
2. Dammann O, Leviton A. Inflammatory brain damage in preterm newborns-dry numbers, wet lab, and causal inferences. Early Hum Dev. 2004; 79(1): 1-15.
3. Leviton A. Why the term neonatal encephalopathy should be preferred over neonatal hypoxic-ischemic encephalopathy. Am J Obstet Gynecol. 2012; 2012: 23.
4. Lee J, Croen LA, Lindan C, Nash KB, Yoshida CK, Ferriero DM, et al. Predictors of outcome in perinatal arterial stroke: a population-based study. Ann Neurol. 2005; 58(2): 303-8.
5. Lawn JE, Kinney M, Lee AC, Chopra M, Donnay F, Paul VK, et al. Reducing intrapartum-related deaths and disability: can the health system deliver? Int J Gynecol Obstet. 2009; 07 Suppl(1): S123-40-S40-2.
6. Woodward LJ, Anderson PJ, Austin NC, Howard K, Inder TE. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med. 2006; 355(7): 685-94.
7. Mallard C, Welin AK, Peebles D, Hagberg H, Kjellmer I. White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem Res. 2003; 28(2): 215-23.
8. Mallard EC, Williams CE, Johnston BM, Gluckman PD. Increased vulnerability to neuronal damage after umbilical cord occlusion in fetal sheep with advancing gestation. Am J Obstet Gynecol. 1994; 170(1 Pt 1): 206-14.
9. Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic-ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ. 2010; 340: c363.
10. Rutherford MA, Azzopardi D, Whitelaw A, Cowan F, Renowden S, Edwards AD, et al. Mild hypothermia and the distribution of cerebral lesions in neonates with hypoxic-ischemic encephalopathy. Pediatrics. 2005; 116(4): 1001-6.
11. Shankaran S, Pappas A, McDonald SA, Vohr BR, Hintz SR, Yolton K, et al. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med. 2012; 366(22): 2085-92.
12. Johnston MV, Fatemi A, Wilson MA, Northington F. Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol. 2011; 10(4): 372-82.
13. Titomanlio L, Kavelaars A, Dalous J, Mani S, El Ghouzzi V, Heijnen C, et al. Stem cell therapy for neonatal brain injury: perspectives and challenges. Ann Neurol. 2011; 70(5): 698-712.
14. Robertson NJ, Tan S, Groenendaal F, van Bel F, Juul SE, Bennet L, et al. Which neuroprotective agents are ready for bench to bedside translation in the newborn infant? J Pediactrics. 2012; 160(4): 544-52 e4.
15. Fleiss B, Gressens P. Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy? Lancet Neurol. 2012; 11(6): 556-66.
16. Fan P, Yamauchi T, Noble LJ, Ferriero DM. Age-dependent differences in glutathione peroxidase activity after traumatic brain injury. J Neurotrauma. 2003; 20(5): 437-45.
17. Vexler ZS, Ferriero DM. Molecular and biochemical mechanisms of perinatal brain injury. Semin Neonatol. 2001; 6(2): 99-108.
18. Mesples B, Plaisant F, Fontaine RH, Gressens P. Pathophysiology of neonatal brain lesions: lessons from animal models of excitotoxicity. Acta Paediatr. 2005; 94(2): 185-90.
19. Hagberg H, Peebles D, Mallard C. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev. 2002; 8(1): 30-8.
20. Scafidi J, Fagel DM, Ment LR, Vaccarino FM. Modeling premature brain injury and recovery. Int J Dev Neurosc. 2009; 27(8): 863-71.
21. Silbereis JC, Huang EJ, Back SA, Rowitch DH. Towards improved animal models of neonatal white matter injury associated with cerebral palsy. Dis Model Mech. 2010; 3(11-12): 678-88.
22. Vannucci RC, Vannucci SJ. Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev Neurosci. 2005; 27(2-4): 81-6.
23. Eklind S, Hagberg H, Wang X, Savman K, Leverin AL, Hedtjarn M, et al. Effect of lipopolysaccharide on global gene expression in the immature rat brain. Pediatr Res. 2006; 60(2): 161-8.
24. Sizonenko SV, Sirimanne E, Mayall Y, Gluckman PD, Inder T, Williams C. Selective cortical alteration after hypoxic-ischemic injury in the very immature rat brain. Pediatr Res. 2003; 54(2): 263-9.
25. Derugin N, Ferriero DM, Vexler ZS. Neonatal reversible focal cerebral ischemia: a new model. Neurosci Res. 1998; 32(4): 349-53.
26. O'Brien FE, Iwata O, Thornton JS, De Vita E, Sellwood MW, Iwata S, et al. Delayed whole-body cooling to 33 or 35 degrees C and the development of impaired energy generation consequential to transient cerebral hypoxia-schemia in the newborn piglet. Pediatrics. 2006; 117(5): 1549-59.
27. Gressens P, Dingley J, Plaisant F, Porter H, Schwendimann L, Verney C, et al. Analysis of neuronal, glial, endothelial, axonal and apoptotic markers following moderate therapeutic hypothermia and anesthesia in the developing piglet brain. Brain Pathol. 2008; 18(1): 10-20.
28. Powell E, Faulkner S, Bainbridge A, Kereyni A, Kelen D, Chandrasekaran M, et al. Improved neuroprotection with melatonin-augmented hypothermia vs hypothermia alone in a perinatal asphyxia model: a randomized study. Pediatr Res. 2011; 70: 67.
29. Thoresen M, Penrice J, Lorek A, Cady EB, Wylezinska M, Kirkbride V, et al. Mild hypothermia after severe transient hypoxia-ischemia ameliorates delayed cerebral energy failure in the newborn piglet. Pediatr Res. 1995; 37(5): 667-70.
30. Chahboune H, Ment LR, Stewart WB, Rothman DL, Vaccarino FM, Hyder F, et al. Hypoxic injury during neonatal development in murine brain: correlation between in vivo DTI findings and behavioral assessment. Cereb Cortex. 2009; 19(12): 2891-901.
31. Scafidi S, O'Brien J, Hopkins I, Robertson C, Fiskum G, McKenna M. Delayed cerebral oxidative glucose metabolism after traumatic brain injury in young rats. J Neurochem. 2009; 109 Suppl 1: 189-97.
32. Baud O, Daire JL, Dalmaz Y, Fontaine RH, Krueger RC, Sebag G, et al. Gestational hypoxia induces white matter damage in neonatal rats: a new model of periventricular leukomalacia. Brain Pathol. 2004; 14(1): 1-10.
33. Olivier P, Fontaine RH, Loron G, van Steenwinckel J, Biran V, Massonneau V, et al. Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats. PLoS One. 2009; 4(9): e7128.
34. Tan S, Drobyshevsky A, Jilling T, Ji X, Ullman LM, Englof I, et al. Model of cerebral palsy in the perinatal rabbit. J Child Neurol. 2005; 20(12): 972-9.
35. Miller SL, Yan EB, Castillo-Melendez M, Jenkin G, Walker DW. Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion. Dev Neurosci. 2005; 27(2-4): 200-10.
36. Welin AK, Svedin P, Lapatto R, Sultan B, Hagberg H, Gressens P, et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res. 2007; 61(2): 153-8.
37. Riddle A, Dean J, Buser JR, Gong X, Maire J, Chen K, et al. Histopathological correlates of magnetic resonance imaging-defined chronic perinatal white matter injury. Ann Neurol. 2011; 70(3): 493-507.
38. van de Looij Y, Lodygensky GA, Dean J, Lazeyras F, Hagberg H, Kjellmer I, et al. High-field diffusion tensor imaging characterization of cerebral white matter injury in LPS-exposed fetal sheep. Pediatr Res. 2012;(in press).
39. Hutton LC, Abbass M, Dickinson H, Ireland Z, Walker DW. Neuroprotective properties of melatonin in a model of birth asphyxia in the spiny mouse (Acomys cahirinus). Dev Neurosci. 2009; 31(5): 437-51.
40. Fleiss B, Coleman HA, Castillo-Melendez M, Ireland Z, Walker DW, Parkington HC. Effects of birth asphyxia on neonatal hippocampal structure and function in the spiny mouse. Int J Dev Neuro. 2011; 29(7): 757-66.
41. Juul SE, Aylward E, Richards T, McPherson RJ, Kuratani J, Burbacher TM. Prenatal cord clamping in newborn Macaca nemestrina: a model of perinatal asphyxia. Dev Neurosci. 2007; 29(4-5): 311-20.
42. Jacobson Misbe EN, Richards TL, McPherson RJ, Burbacher TM, Juul SE. Perinatal asphyxia in a nonhuman primate model. Dev Neurosci. 2011; 33(3-4): 210-21.
43. Inder T, Neil J, Kroenke C, Dieni S, Yoder B, Rees S. Investigation of cerebral development and injury in the prematurely born primate by magnetic resonance imaging and histopathology. Dev Neurosci. 2005; 27(2-4): 100-11.
44. Verney C, Rees S, Biran V, Thompson M, Inder T, Gressens P. Neuronal damage in the preterm baboon: impact of the mode of ventilatory support. J Neuropathol Exp Neurol. 2010; 69(5): 473-82.
45. Wang X, Rousset CI, Hagberg H, Mallard C. Lipopolysaccharide-induced inflammation and perinatal brain injury. Semin Fetal Neonatal Med. 2006; 11(5): 343-53.
46. Rousset CI, Kassem J, Olivier P, Chalon S, Gressens P, Saliba E. Antenatal bacterial endotoxin sensitizes the immature rat brain to postnatal excitotoxic injury. J Neuropathol Exp Neurol. 2008; 67(10): 994-1000.
47. Yoon BH, Kim CJ, Romero R, Jun JK, Park KH, Choi ST, et al. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol. 1997; 177(4): 797-802.
48. Debillon T, Gras-Leguen C, Leroy S, Caillon J, Roze JC, Gressens P. Patterns of cerebral inflammatory response in a rabbit model of intrauterine infection-mediated brain lesion. Brain Res Dev Brain Res. 2003; 145(1): 39-48.
49. Gressens P, Schwendimann L, Husson I, Sarkozy G, Mocaer E, Vamecq J, et al. Agomelatine, a melatonin receptor agonist with 5-HT(2C) receptor antagonist properties, protects the developing murine white matter against excitotoxicity. Eur J Pharmacol. 2008; 588(1): 58-63.
50. Du X, Fleiss B, Li H, D'Angelo B, Sun Y, Zhu C, et al. Systemic stimulation of TLR2 impairs neonatal mouse brain development. PLoS One. 2011; 6(5): e19583.
51. Favrais G, van de Looij Y, Fleiss B, Ramanantsoa N, Bonnin P, Stoltenburg-Didinger G, et al. Systemic inflammation disrupts the developmental program of white matter. Ann Neurol. 2011; 70(4): 550-65.
52. Chen YH, Xu DX, Wang JP, Wang H, Wei LZ, Sun MF, et al. Melatonin protects against lipopolysaccharide-induced intra-uterine fetal death and growth retardation in mice. J Pineal Res. 2006; 40(1): 40-7.
53. Marret S, Mukendi R, Gadisseux JF, Gressens P, Evrard P. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol. 1995; 54(3): 358-70.
54. Bac P, Maurois P, Dupont C, Pages N, Stables JP, Gressens P, et al. Magnesium deficiency-dependent audiogenic seizures (MDDASs) in adult mice: a nutritional model for discriminatory screening of anticonvulsant drugs and original assessment of neuroprotection properties. J Neurosci. 1998; 18(11): 4363-73.
55. Husson I, Mesples B, Bac P, Vamecq J, Evrard P, Gressens P. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol. 2002; 51(1): 82-92.
56. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci. 2000; 20(24): 9235-41.
57. Schmadel S, Schwabe K, Koch M. Effects of neonatal excitotoxic lesions of the entorhinal cortex on cognitive functions in the adult rat. Neuroscience. 2004; 128(2): 365-74.
58. Carrillo-Vico A, Calvo JR, Abreu P, Lardone PJ, Garcia-Maurino S, Reiter RJ, et al. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J. 2004; 18(3): 537-9.
59. Nguyen-Legros J, Chanut E, Versaux-Botteri C, Simon A, Trouvin JH. Dopamine inhibits melatonin synthesis in photoreceptor cells through a D2-like receptor subtype in the rat retina: biochemical and histochemical evidence. J Neurochem. 1996; 67(6): 2514-20.
60. Gern WA, Ralph CL. Melatonin synthesis by the retina. Science. 1979; 204(4389): 183-4.
61. Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B, Hardeland R. Melatonin: Nature's most versatile biological signal? FEBS J. 2006; 273(13): 2813-38.
62. Reiter RJ, Tan DX, Qi W, Manchester LC, Karbownik M, Calvo JR. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol Sign Recept. 2000; 9(3-4): 160-71.
63. Poeggeler B, Reiter RJ, Tan DX, Chen LD, Manchester LC. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J Pineal Res. 1993; 14(4): 151-68.
64. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine. 2005; 27(2): 189-200.
65. Yon JH, Carter LB, Reiter RJ, Jevtovic-Todorovic V. Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiol Dis. 2006; 21(3): 522-30.
66. Andrabi SA, Sayeed I, Siemen D, Wolf G, Horn TF. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J. 2004; 18(7): 869-71.
67. Blask DE, Sauer LA, Dauchy RT. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem. 2002; 2(2): 113-32.
68. Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT. Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol. 2012; 351(2): 152-66.
69. Benitez-King G, Huerto-Delgadillo L, Anton-Tay F. Binding of 3H-melatonin to calmodulin. Life Sci. 1993; 53(3): 201-7.
70. Sanchez-Barcelo EJ, Mediavilla MD, Reiter RJ. Clinical uses of melatonin in pediatrics. Int J Pediatr. 2011; 2011: 892624.
71. Jan JE, O'Donnell ME. Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res. 1996; 21(4): 193-9.
72. Gitto E, Reiter RJ, Cordaro SP, La Rosa M, Chiurazzi P, Trimarchi G, et al. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol. 2004; 21(4): 209-16.
73. Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, et al. Effects of melatonin treatment in septic newborns. Pediatr Res. 2001; 50(6): 756-60.
74. Gitto E, Reiter RJ, Amodio A, Romeo C, Cuzzocrea E, Sabatino G, et al. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res. 2004; 36(4): 250-5.
75. Leconte I, Bailey G, Davis-Bruno K, Hew KW, Kim J, Silva Lima B, et al. Value of juvenile animal studies. Birth Defects Res B Dev Reprod Toxicol. 2011; 92(4): 292-303.
76. Morford LL, Bowman CJ, Blanset DL, Bogh IB, Chellman GJ, Halpern WG, et al. Preclinical safety evaluations supporting pediatric drug development with biopharmaceuticals: strategy, challenges, current practices. Birth Defects Res B Dev Reprod Toxicol. 2011; 92(4): 359-80.
77. FDA CfDEaR (2006) Nonclinical Safety Evaluation of Pediatric Drug Products. (FDA), F. a. D. A., ed). http://www. fda. gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079247. pdf.
78. Guideline on the need for non-clinical testing in juvenile animals of pharmaceuticals for pediatric indications, EMEA/CHMP/SWP/169215/2005 (2005).
79. Espinar A, Garcia-Oliva A, Isorna EM, Quesada A, Prada FA, Guerrero JM. Neuroprotection by melatonin from glutamate-induced excitotoxicity during development of the cerebellum in the chick embryo. J Pineal Res. 2000; 28(2): 81-8.
80. Gitto E, Reiter RJ, Sabatino G, Buonocore G, Romeo C, Gitto P, et al. Correlation among cytokines, bronchopulmonary dysplasia and modality of ventilation in preterm newborns: improvement with melatonin treatment. J Pineal Res. 2005; 39(3): 287-93.
81. Carloni S, Perrone S, Buonocore G, Longini M, Proietti F, Balduini W. Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res. 2008; 44(2): 157-64.
82. Mace E, Montaldo G, Cohen I, Baulac M, Fink M, Tanter M. Functional ultrasound imaging of the brain. Nat Methods. 2011; 8(8): 662-4.
83. Hunter CJ, Bennet L, Power GG, Roelfsema V, Blood AB, Quaedackers JS, et al. Key neuroprotective role for endogenous adenosine A1 receptor activation during asphyxia in the fetal sheep. Stroke. 2003; 34(9): 2240-5.
84. Robertson NJ, Faulkner S, Fleiss B, Bainbridge A, Andorka C, Price D, et al. Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain. 2012; (in press).
85. Dutra F, Banchero G. Polwarth and Texel ewe parturition duration and its association with lamb birth asphyxia. J Anim Sci. 2011; 89(10): 3069-78.
86. Baburamani AA, Cabalag C, Castillo-Melendez M, Hutton LC, Walker D. Consequences of brief, prenatal asphyxia on pregnancy outcome, brain development and newborn lamb behaviour in sheep. Fetal and Neonatal Society 35th Annual Meeting, Maastricht, Netherlands. 2008; Abstract 0802.
87. Dilger RN, Johnson RW. Behavioral assessment of cognitive function using a translational neonatal piglet model. Brain Behav Immun. 2010; 24(7): 1156-65.
88. Marklund SL. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J. 1984; 222(3): 649-55.
89. Markert CL, Moller F. Multiple forms of enzymes: tissue, ontogenetic, and species specific patterns. Proc Natl Acad Sci U S A. 1959; 45(5): 753-63.
90. Dieni S, Inder T, Yoder B, Briscoe T, Camm E, Egan G, et al. The pattern of cerebral injury in a primate model of preterm birth and neonatal intensive care. J Neuropathol Exp Neurol. 2004; 63(12): 1297-309.
91. Rees S, Loeliger M, Shields A, Shaul PW, McCurnin D, Yoder B, et al. The effects of postnatal estrogen therapy on brain development in preterm baboons. Am J Obstet Gynecol. 2011; 204(2): 177 e8-14.
92. Rees SM, Camm EJ, Loeliger M, Cain S, Dieni S, McCurnin D, et al. Inhaled nitric oxide: effects on cerebral growth and injury in a baboon model of premature delivery. Pediatr Res. 2007; 61(5 Pt 1): 552-8.
93. Nunez JL, McCarthy MM. Estradiol exacerbates hippocampal damage in a model of preterm infant brain injury. Endocrinology. 2003; 144(6): 2350-9.
94. Feng Y, Fratkins JD, LeBlanc MH. Estrogen attenuates hypoxic-ischemic brain injury in neonatal rats. Eur J Pharmacol. 2005; 507(1-3): 77-86.
95. Nijboer CH, Groenendaal F, Kavelaars A, Hagberg HH, van Bel F, Heijnen CJ. Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway. J Cereb Blood Flow Metab. 2007; 27(2): 282-92.
96. Charriaut-Marlangue C, Bonnin P, Gharib A, Leger PL, Villapol S, Pocard M, et al. Inhaled nitric oxide reduces brain damage by collateral recruitment in a neonatal stroke model. Stroke. 2012; 43(11): 3078-84.
97. Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol. 2004; 56(3): 407-15.
98. Zarow C, Kim TS, Singh M, Chui HC. A standardized method for brain-cutting suitable for both stereology and MRI-brain co-registration. J Neurosci Methods. 2004; 139(2): 209-15.
99. Singh M, Rajagopalan A, Kim TS, Hwang D, Chui H, Zhang XL, et al. Co-registration of in-vivo human MRI brain images to postmortem histological microscopic images. Int J Imaging Syst Technol. 2008; 18(5-6): 325-35.
100. Drake C, Boutin H, Jones MS, Denes A, McColl BW, Selvarajah JR, et al. Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun. 2011; 25(6): 1113-22.
101. Pradillo JM, Denes A, Greenhalgh AD, Boutin H, Drake C, McColl BW, et al. Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats. J Cereb Blood Flow Metab. 2012; 32(9): 1810-9.
102. Gressens P, Rogido M, Paindaveine B, Sola A. The impact of neonatal intensive care practices on the developing brain. J Pediatr. 2002; 140(6): 646-53.
103. Walker SM. Management of procedural pain in NICUs remains problematic. Paediatr Anaesth. 2005; 15(11): 909-12.
104. Sanders RD, Davidson A. Anesthetic-induced neurotoxicity of the neonate: time for clinical guidelines? Paediatr Anaesth. 2009; 19(12): 1141-6.
105. Thoresen M, Satas S, Loberg EM, Whitelaw A, Acolet D, Lindgren C, et al. Twenty-four hours of mild hypothermia in unsedated newborn pigs starting after a severe global hypoxic-ischemic insult is not neuroprotective. Pediatr Res. 2001; 50(3): 405-11.
106. Faulkner S, Bainbridge A, Kato T, Chandrasekaran M, Kapetanakis AB, Hristova M, et al. Xenon augmented hypothermia reduces early lactate/N-acetylaspartate and cell death in perinatal asphyxia. Ann Neurol. 2011; 70(1): 133-50.
107. Simbruner G, Mittal RA, Rohlmann F, Muche R. Systemic hypothermia after neonatal encephalopathy: outcomes of neo. nEURO. network RCT. Pediatrics. 2010; 126(4): e771-8.
108. Brummelte S, Grunau RE, Chau V, Poskitt KJ, Brant R, Vinall J, et al. Procedural pain and brain development in premature newborns. Ann Neurol. 2012; 71(3): 385-96.
109. Liu X, Tooley J, Loberg EM, Suleiman MS, Thoresen M. Immediate hypothermia reduces cardiac troponin I after hypoxic-ischemic encephalopathy in newborn pigs. Pediatr Res. 2011; 70(4): 352-6.
110. Pedreira PR, Garcia-Prieto E, Parra D, Astudillo A, Diaz E, Taboada F, et al. Effects of melatonin in an experimental model of ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol. 2008; 295(5): L820-7.
111. Pan L, Fu JH, Xue XD, Xu W, Zhou P, Wei B. Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia. World J Pediatr. 2009; 5(3): 216-21.
112. Yamori Y, Horie R, Handa H, Sato M, Fukase M. Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke. 1976; 7(1): 46-53.
113. Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, et al. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol. 1998; 147(3): 259-68.
114. Tioseco JA, Aly H, Essers J, Patel K, El-Mohandes AA. Male sex and intraventricular hemorrhage. Pediatr Crit Care Med. 2006; 7(1): 40-4.
115. Reisert I, Lieb K, Beyer C, Pilgrim C. Sex differentiation of rat hippocampal GABAergic neurons. Eur J Neurosci. 1996; 8(8): 1718-24.
116. Dewing P, Shi T, Horvath S, Vilain E. Sexually dimorphic gene expression in mouse brain precedes gonadal differentiation. Brain Res Mol Brain Res. 2003; 118(1-2): 82-90.
117. McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab. 2005; 25(4): 502-12.
118. Loihl AK, Asensio V, Campbell IL, Murphy S. Expression of nitric oxide synthase (NOS)-2 following permanent focal ischemia and the role of nitric oxide in infarct generation in male, female and NOS-2 gene-deficient mice. Brain Res. 1999; 830(1): 155-64.
119. McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab. 2005; 25(4): 502-12.
120. Liu F, Li Z, Li J, Siegel C, Yuan R, McCullough LD. Sex differences in caspase activation after stroke. Stroke. 2009; 40(5): 1842-8.
121. Fleiss B, Nilsson MK, Blomgren K, Mallard C. Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury. J Neuroinflammation. 2012; 9(1): 70.
122. Wang X, Stridh L, Li W, Dean J, Elmgren A, Gan L, et al. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol. 2009; 183(11): 7471-7.
123. Aden U, Favrais G, Plaisant F, Winerdal M, Felderhoff-Mueser U, Lampa J, et al. Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept. Brain Behav Immun. 2010; 24(5): 747-58.
124. Wang X, Hagberg H, Nie C, Zhu C, Ikeda T, Mallard C. Dual role of intrauterine immune challenge on neonatal and adult brain vulnerability to hypoxia-ischemia. J Neuropathol Exp Neurol. 2007; 66(6): 552-61.
125. Dean JM, Wang X, Kaindl AM, Gressens P, Fleiss B, Hagberg H, et al. Microglial MyD88 signaling regulates acute neuronal toxicity of LPS-stimulated microglia in vitro. Brain Behav Immun. 2009 Nov 10.
126. Johansson BB. Functional outcome in rats transferred to an enriched environment 15 days after focal brain ischemia. Stroke. 1996; 27(2): 324-6.
127. Ortuzar N, Argandona EG, Bengoetxea H, Lafuente JV. Combination of intracortically administered VEGF and environmental enrichment enhances brain protection in developing rats. J Neural Transm. 2011; 118(1): 135-44.
128. Will B, Galani R, Kelche C, Rosenzweig MR. Recovery from brain injury in animals: relative efficacy of environmental enrichment, physical exercise or formal training (1990-2002). Prog Neurobiol. 2004; 72(3): 167-82.
129. Cotman CW, Berchtold NC, Christie LA. Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends Neurosci. 2007; 30(9): 464-72.
130. Cilio MR, Ferriero DM. Synergistic neuroprotective therapies with hypothermia. Semin Fetal Neonatal Med. 2010; 15(5): 293-8.
131. Gunn AJ, Gluckman PD, Gunn TR. Selective head cooling in newborn infants after perinatal asphyxia: a safety study. Pediatrics. 1998; 102(4 Pt 1): 885-92.
132. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005; 353(15): 1574-84.
133. Filippi L, la Marca G, Cavallaro G, Fiorini P, Favelli F, Malvagia S, et al. Phenobarbital for neonatal seizures in hypoxic-ischemic encephalopathy: a pharmacokinetic study during whole body hypothermia. Epilepsia. 2011; 52(4): 794-801.
134. Tortorici MA, Kochanek PM, Poloyac SM. Effects of hypothermia on drug disposition, metabolism, and response: a focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system. Crit Care Med. 2007; 35(9): 2196-204.
135. Kotler M, Rodriguez C, Sainz RM, Antolin I, Menendez-Pelaez A. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res. 1998; 24(2): 83-9.
136. Penev PD, Zee PC. Melatonin: a clinical perspective. Ann Neurol. 1997; 42(4): 545-53.
137. Marlow N, Wolke D, Bracewell MA, Samara M. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J. 2005; 352(1): 9-19.
138. Arnaud C, Daubisse-Marliac L, White-Koning M, Pierrat V, Larroque B, Grandjean H, et al. Prevalence and associated factors of minor neuromotor dysfunctions at age 5 years in prematurely born children: the EPIPAGE Study. Arch Pediatr Adolesc Med. 2007; 161(11): 1053-61.
139. Briscoe J, Gathercole SE, Marlow N. Short-term memory and language outcomes after extreme prematurity at birth. J Speech Lang Hear Res. 1998; 41(3): 654-66.
140. Lawrence EJ, McGuire PK, Allin M, Walshe M, Giampietro V, Murray RM, et al. The very preterm brain in young adulthood: the neural correlates of verbal paired associate learning. J Pediatr. 2010; 156(6): 889-95.
141. McDowell BC, Kerr C, Parkes J, Cosgrove A. Validity of a 1 minute walk test for children with cerebral palsy. Dev Med Child Neurol. 2005; 47(11): 744-8.
142. van der Staay FJ, Steckler T. Behavioural phenotyping of mouse mutants. Behav Brain Res. 2001; 125(1-2): 3-12.
143. Arndt SS, Surjo D. Methods for the behavioural phenotyping of mouse mutants. How to keep the overview. Behav Brain Res. 2001; 125(1-2): 39-42.
144. Surjo D, Arndt SS. The Mutant Mouse Behaviour network, a medium to present and discuss methods for the behavioural phenotyping. Physiol Behav. 2001; 73(5): 691-4.
145. Crawley JN. Behavioral phenotyping strategies for mutant mice. Neuron. 2008; 57(6): 809-18.
146. Fox WM. Reflex-ontogeny and behavioural development of the mouse. Anim Behav. 1965; 13(2): 234-41.
147. Hammerschmidt K, Reisinger E, Westekemper K, Ehrenreich L, Strenzke N, Fischer J. Mice do not require auditory input for the normal development of their ultrasonic vocalizations. BMC Neurosci. 2012; 13: 40.
148. Scattoni ML, Crawley J, Ricceri L. Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci Biobehav Rev. 2009; 33(4): 508-15.
149. Blumberg MS, Sokoloff G. Do infant rats cry? Psychol Rev. 2001; 108(1): 83-95.
150. Young DM, Schenk AK, Yang SB, Jan YN, Jan LY. Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism. Proc Natl Acad Sci U S A. 2010; 107(24): 11074-9.
151. Bouslama M, Durand E, Chauviere L, van den Bergh O, Gallego J. Olfactory classical conditioning in newborn mice. Behav Brain Res. 2005; 161(1): 102-6.
152. Wilson DA, Sullivan RM. Neurobiology of associative learning in the neonate: early olfactory learning. Behav Neural Biol. 1994; 61(1): 1-18.
153. Gallego J. Genetic diseases: congenital central hypoventilation, Rett, and Prader-Willi syndromes. Compr Physiol. 2012; 2: 2255-79.
154. Bouslama M, Renaud J, Olivier P, Fontaine RH, Matrot B, Gressens P, et al. Melatonin prevents learning disorders in brain-lesioned newborn mice. Neuroscience. 2007; 150(3): 712-9.
155. Bouslama M, Chauviere L, Fontaine RH, Matrot B, Gressens P, Gallego J. Treatment-induced prevention of learning deficits in newborn mice with brain lesions. Neuroscience. 2006; 141(2): 795-801.
156. Spittle AJ, Boyd RN, Inder TE, Doyle LW. Predicting motor development in very preterm infants at 12 months' corrected age: the role of qualitative magnetic resonance imaging and general movements assessments. Pediatrics. 2009; 123(2): 512-7.
157. Pham H, Vottier G, Pansiot J, Duong-Quy S, Bollen B, Dalous J, et al. Impact of inhaled nitric oxide on hyperoxia-induced white matter damage in neonatal rats. Pediatric Academic Societies Meeting; April 28-May 1; Boston 2012.
158. Sullivan RM, Taborsky-Barba S, Mendoza R, Itano A, Leon M, Cotman CW, et al. Olfactory classical conditioning in neonates. Pediatrics. 1991; 87(4): 511-8.
159. Bollen B, Matrot B, Ramanantsoa N, van den Bergh O, D'Hooge R, Gallego J. Olfactory classical conditioning in neonatal mouse pups using thermal stimuli. Behav Brain Res. 2012; 229(1): 250-6.
160. Mandillo S, Tucci V, Holter SM, Meziane H, Banchaabouchi MA, Kallnik M, et al. Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study. Physiol Genom. 2008; 34(3): 243-55.
161. Fuchs H, Gailus-Durner V, Adler T, Aguilar-Pimentel JA, Becker L, Calzada-Wack J, et al. Mouse phenotyping. Methods. 2011; 53(2): 120-35.
162. Stiles J, Reilly J, Paul B, Moses P. Cognitive development following early brain injury: evidence for neural adaptation. Trends Cogn Sci. 2005; 9(3): 136-43.
163. Luciana M, Lindeke L, Georgieff M, Mills M, Nelson CA. Neurobehavioral evidence for working-memory deficits in school-aged children with histories of prematurity. Dev Med Child Neurol. 1999; 41(8): 521-33.
164. Bates JH, Thompson-Figueroa J, Lundblad LK, Irvin CG. Unrestrained video-assisted plethysmography: a noninvasive method for assessment of lung mechanical function in small animals. J Appl Physiol. 2008; 104(1): 253-61.
165. Dehorter N, Michel FJ, Marissal T, Rotrou Y, Matrot B, Lopez C, et al. Onset of pup locomotion coincides with loss of NR2C/D-mediated cortico-striatal EPSCs and dampening of striatal network immature activity. Front Cell Neurosci. 2011; 5: 24.
166. Moy SS, Nadler JJ. Advances in behavioral genetics: mouse models of autism. Mol Psychiatry. 2008; 13(1): 4-26.
167. Pautassi RM, Nizhnikov ME, Truxell E, Varlinskaya EI, Spear NE. Ontogeny of ethanol intake in alcohol preferring (P) and alcohol nonpreferring (NP) rats. Dev Psychobiol. 2011; 53(3): 234-45.
168. Flory GS, Langley CM, Pfister JF, Alberts JR. Instrumental learning for a thermal reinforcer in 1-day-old rats. Dev Psychobiol. 1997; 30(1): 41-7.